Simpler Grants.gov #FOR-FD-25-001

FDA Grant for Clinical Trials in Rare Neurodegenerative Diseases

The Food and Drug Administration (FDA) is offering a grant opportunity to support clinical trials for rare neurodegenerative diseases in both children and adults. - Government Buyer: - Food and Drug Administration (FDA) - Products/Services Requested: - Clinical trial services to evaluate the efficacy and/or safety of products for new indications or labeling changes - Focus on rare neurodegenerative diseases with unmet medical needs - OEMs and Vendors: - No specific Original Equipment Manufacturers (OEMs) or vendors are named in this opportunity - Notable Requirements: - Clinical trials must address rare neurodegenerative diseases - Studies should support new indications or labeling changes to increase approved treatments - Open to a wide range of applicants: government entities, nonprofits, educational institutions, and businesses - No cost sharing or matching required - Funding instrument is a grant, with a minimum award of $900,000 and expected awards around $650,000

Description

This funding opportunity by the Food and Drug Administration aims to support clinical trials evaluating the efficacy and/or safety of products for new indications or labeling changes to address unmet needs in rare neurodegenerative diseases affecting children and adults. The goal is to increase the number of approved treatments for these rare diseases through collaborative, efficient, and innovative clinical trials. Eligible applicants include various government entities, nonprofits, educational institutions, and businesses. The award minimum is $900,000 with expected awards around $650,000, and the funding instrument is a grant.

View original listing